Type |
Details |
Score |
Publication |
First Author: |
Magdaleno S |
Year: |
2006 |
Journal: |
PLoS Biol |
Title: |
BGEM: an in situ hybridization database of gene expression in the embryonic and adult mouse nervous system. |
Volume: |
4 |
Issue: |
4 |
Pages: |
e86 |
|
•
•
•
•
•
|
Publication |
First Author: |
Carninci P |
Year: |
2005 |
Journal: |
Science |
Title: |
The transcriptional landscape of the mammalian genome. |
Volume: |
309 |
Issue: |
5740 |
Pages: |
1559-63 |
|
•
•
•
•
•
|
Publication |
First Author: |
MGD Nomenclature Committee |
Year: |
1995 |
|
Title: |
Nomenclature Committee Use |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
GemPharmatech |
Year: |
2020 |
|
Title: |
GemPharmatech Website. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Skarnes WC |
Year: |
2011 |
Journal: |
Nature |
Title: |
A conditional knockout resource for the genome-wide study of mouse gene function. |
Volume: |
474 |
Issue: |
7351 |
Pages: |
337-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cyagen Biosciences Inc. |
Year: |
2022 |
|
Title: |
Cyagen Biosciences Website. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
AgBase, BHF-UCL, Parkinson's UK-UCL, dictyBase, HGNC, Roslin Institute, FlyBase and UniProtKB curators |
Year: |
2011 |
|
Title: |
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
UniProt-GOA |
Year: |
2012 |
|
Title: |
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
GOA curators |
Year: |
2016 |
|
Title: |
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
The Gene Ontology Consortium |
Year: |
2010 |
|
Title: |
Automated transfer of experimentally-verified manual GO annotation data to mouse-human orthologs |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Diez-Roux G |
Year: |
2011 |
Journal: |
PLoS Biol |
Title: |
A high-resolution anatomical atlas of the transcriptome in the mouse embryo. |
Volume: |
9 |
Issue: |
1 |
Pages: |
e1000582 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2002 |
|
Title: |
Mouse Genome Informatics Computational Sequence to Gene Associations |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2010 |
Journal: |
Database Download |
Title: |
Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome U74 Array Platform (A, B, C v2). |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
MGI Genome Annotation Group and UniGene Staff |
Year: |
2015 |
Journal: |
Database Download |
Title: |
MGI-UniGene Interconnection Effort |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Marc Feuermann, Huaiyu Mi, Pascale Gaudet, Dustin Ebert, Anushya Muruganujan, Paul Thomas |
Year: |
2010 |
|
Title: |
Annotation inferences using phylogenetic trees |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Database and National Center for Biotechnology Information |
Year: |
2000 |
Journal: |
Database Release |
Title: |
Entrez Gene Load |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Allen Institute for Brain Science |
Year: |
2004 |
Journal: |
Allen Institute |
Title: |
Allen Brain Atlas: mouse riboprobes |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2009 |
Journal: |
Database Download |
Title: |
Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Gene 1.0 ST Array Platform |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics (MGI) and The National Center for Biotechnology Information (NCBI) |
Year: |
2010 |
Journal: |
Database Download |
Title: |
Consensus CDS project |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Group |
Year: |
2003 |
Journal: |
Database Procedure |
Title: |
Automatic Encodes (AutoE) Reference |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Bairoch A |
Year: |
1999 |
Journal: |
Database Release |
Title: |
SWISS-PROT Annotated protein sequence database |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2005 |
|
Title: |
Obtaining and Loading Genome Assembly Coordinates from Ensembl Annotations |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics |
Year: |
2010 |
Journal: |
Database Release |
Title: |
Protein Ontology Association Load. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2005 |
|
Title: |
Obtaining and loading genome assembly coordinates from NCBI annotations |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2009 |
Journal: |
Database Download |
Title: |
Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome 430 2.0 Array Platform |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Ng AN |
Year: |
2023 |
Journal: |
iScience |
Title: |
Amyloid-β(1-42) oligomers enhance mGlu(5)R-dependent synaptic weakening via NMDAR activation and complement C5aR1 signaling. |
Volume: |
26 |
Issue: |
12 |
Pages: |
108412 |
|
•
•
•
•
•
|
Publication |
First Author: |
Titiz M |
Year: |
2024 |
Journal: |
Nat Commun |
Title: |
Schwann cell C5aR1 co-opts inflammasome NLRP1 to sustain pain in a mouse model of endometriosis. |
Volume: |
15 |
Issue: |
1 |
Pages: |
10142 |
|
•
•
•
•
•
|
Allele |
Name: |
complement component 5a receptor 1; endonuclease-mediated mutation 2, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Allele |
Name: |
complement component 5a receptor 1; endonuclease-mediated mutation 3, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Allele |
Name: |
complement component 5a receptor 1; targeted mutation 1, Shanghai Model Organisms Center |
Allele Type: |
Targeted |
Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
complement component 5a receptor 2; targeted mutation 1, Shanghai Model Organisms Center |
Allele Type: |
Targeted |
Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
complement component 5a receptor 1; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
Allele |
Name: |
complement component 5a receptor 1; targeted mutation 1.1, Charles R Mackay |
Allele Type: |
Targeted |
Attribute String: |
Humanized sequence, Inserted expressed sequence, Null/knockout |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
The activation of the complement cascade produces a number of small fragments that are bioactive: potent chemoattractants and secretagogues that act on immune and non-immune cells []. Similar peptides can also be released by the actions of non-complement proteases, for instance during clotting []. Initially these were termed anaphylatoxins because of their effect on mast cell histamine release, but were reclassified as complement component peptides. They include C3a and C5a, which are involved immune response [], neural development and organ regeneration [, ]. A third peptide, C4a, has a similar structure, but it is inactive in humans []. Since the primary function of complement component peptides is in inflammation, they are important targets for the development of anti-inflammatory therapies [].The anaphylatoxin chemotactic receptors (also known as complement peptide receptors) are a group of rhodopsin-like G-protein coupled receptors (GPCRs) [, , , ]. There are three subtypes: C3a anaphylatoxin chemotactic receptor (C3AR1) [], C5a anaphylatoxin chemotactic receptor (C5AR1) []and C5a anaphylatoxin chemotactic receptor C5L2 (C5AR2) []. Both C3AR1 and C5AR1 receptors are classical GPCRs. However, C5AR2 appears to be permanently uncoupled from G proteins but can associate with beta-arrestin []. Nevertheless, it has been shown that activation of both C5AR1 and C5AR2 is required for a full pro-inflammatory response, particularly in mice []. Several receptor antagonists have been reported [, , , ], although none, so far, have been show to be effective in humans. This entry represents C3a anaphylatoxin chemotactic receptors and C5a anaphylatoxin chemotactic receptor 1/2. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
The activation of the complement cascade produces a number of small fragments that are bioactive: potent chemoattractants and secretagogues that act on immune and non-immune cells []. Similar peptides can also be released by the actions of non-complement proteases, for instance during clotting []. Initially these were termed anaphylatoxins because of their effect on mast cell histamine release, but were reclassified as complement component peptides. They include C3a and C5a, which are involved immune response [], neural development and organ regeneration [, ]. A third peptide, C4a, has a similar structure, but it is inactive in humans []. Since the primary function of complement component peptides is in inflammation, they are important targets for the development of anti-inflammatory therapies [].The anaphylatoxin chemotactic receptors (also known as complement peptide receptors) are a group of rhodopsin-like G-protein coupled receptors (GPCRs) [, , , ]. There are three subtypes: C3a anaphylatoxin chemotactic receptor (C3AR1) [], C5a anaphylatoxin chemotactic receptor (C5AR1) []and C5a anaphylatoxin chemotactic receptor C5L2 (C5AR2) []. Both C3AR1 and C5AR1 receptors are classical GPCRs. However, C5AR2 appears to be permanently uncoupled from G proteins but can associate with beta-arrestin []. Nevertheless, it has been shown that activation of both C5AR1 and C5AR2 is required for a full pro-inflammatory response, particularly in mice []. Several receptor antagonists have been reported [, , , ], although none, so far, have been show to be effective in humans. This entry represents C5AR2, also known as complement component 5a receptor 2. |
|
•
•
•
•
•
|
Publication |
First Author: |
Hartmann K |
Year: |
1997 |
Journal: |
Blood |
Title: |
C3a and C5a stimulate chemotaxis of human mast cells. |
Volume: |
89 |
Issue: |
8 |
Pages: |
2863-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bellows-Peterson ML |
Year: |
2012 |
Journal: |
J Med Chem |
Title: |
De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validation. |
Volume: |
55 |
Issue: |
9 |
Pages: |
4159-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Takafuji S |
Year: |
1994 |
Journal: |
Int Arch Allergy Immunol |
Title: |
Degranulation from human eosinophils stimulated with C3a and C5a. |
Volume: |
104 Suppl 1 |
Issue: |
1 |
Pages: |
27-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schraufstatter IU |
Year: |
2009 |
Journal: |
J Immunol |
Title: |
C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation. |
Volume: |
182 |
Issue: |
6 |
Pages: |
3827-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bera MM |
Year: |
2011 |
Journal: |
J Immunol |
Title: |
Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins. |
Volume: |
187 |
Issue: |
8 |
Pages: |
4245-55 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
The activation of the complement cascade produces a number of small fragments that are bioactive: potent chemoattractants and secretagogues that act on immune and non-immune cells []. Similar peptides can also be released by the actions of non-complement proteases, for instance during clotting []. Initially these were termed anaphylatoxins because of their effect on mast cell histamine release, but were reclassified as complement component peptides. They include C3a and C5a, which are involved immune response [], neural development and organ regeneration [, ]. A third peptide, C4a, has a similar structure, but it is inactive in humans []. Since the primary function of complement component peptides is in inflammation, they are important targets for the development of anti-inflammatory therapies [].The anaphylatoxin chemotactic receptors (also known as complement peptide receptors) are a group of rhodopsin-like G-protein coupled receptors (GPCRs) [, , , ]. There are three subtypes: C3a anaphylatoxin chemotactic receptor (C3AR1) [], C5a anaphylatoxin chemotactic receptor (C5AR1) []and C5a anaphylatoxin chemotactic receptor C5L2 (C5AR2) []. Both C3AR1 and C5AR1 receptors are classical GPCRs. However, C5AR2 appears to be permanently uncoupled from G proteins but can associate with beta-arrestin []. Nevertheless, it has been shown that activation of both C5AR1 and C5AR2 is required for a full pro-inflammatory response, particularly in mice []. Several receptor antagonists have been reported [, , , ], although none, so far, have been show to be effective in humans. This entry represents C3AR1, also known as complement component 3a receptor 1 and C3aR []. It appears to be widely expressed in different lymphoid tissues, providing evidence for a central role in inflammatory processes []. This receptor stimulates chemotaxis [], granule enzyme release [, ]and increases phosphorylated-ERK1/2 production []. C3AR1 may provide a theraputic avenue for the treatment of asthma [], retinal degeneration [], and rheumatoid arthritis []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Kalant D |
Year: |
2005 |
Journal: |
J Biol Chem |
Title: |
C5L2 is a functional receptor for acylation-stimulating protein. |
Volume: |
280 |
Issue: |
25 |
Pages: |
23936-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ames RS |
Year: |
1996 |
Journal: |
J Biol Chem |
Title: |
Molecular cloning and characterization of the human anaphylatoxin C3a receptor. |
Volume: |
271 |
Issue: |
34 |
Pages: |
20231-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Monk PN |
Year: |
2007 |
Journal: |
Br J Pharmacol |
Title: |
Function, structure and therapeutic potential of complement C5a receptors. |
Volume: |
152 |
Issue: |
4 |
Pages: |
429-48 |
|
•
•
•
•
•
|
Publication |
First Author: |
Amara U |
Year: |
2008 |
Journal: |
Adv Exp Med Biol |
Title: |
Interaction between the coagulation and complement system. |
Volume: |
632 |
|
Pages: |
71-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Peng Q |
Year: |
2009 |
Journal: |
Inflamm Allergy Drug Targets |
Title: |
The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses. |
Volume: |
8 |
Issue: |
3 |
Pages: |
236-46 |
|
•
•
•
•
•
|
Publication |
First Author: |
Carmona-Fontaine C |
Year: |
2011 |
Journal: |
Dev Cell |
Title: |
Complement fragment C3a controls mutual cell attraction during collective cell migration. |
Volume: |
21 |
Issue: |
6 |
Pages: |
1026-37 |
|
•
•
•
•
•
|
Publication |
First Author: |
Klos A |
Year: |
2009 |
Journal: |
Mol Immunol |
Title: |
The role of the anaphylatoxins in health and disease. |
Volume: |
46 |
Issue: |
14 |
Pages: |
2753-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lienenklaus S |
Year: |
1998 |
Journal: |
J Immunol |
Title: |
Human anaphylatoxin C4a is a potent agonist of the guinea pig but not the human C3a receptor. |
Volume: |
161 |
Issue: |
5 |
Pages: |
2089-93 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fukuoka Y |
Year: |
1989 |
Journal: |
Dermatologica |
Title: |
Characterization of receptors to the anaphylatoxins on isolated cells. |
Volume: |
179 Suppl 1 |
|
Pages: |
35-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee DK |
Year: |
2001 |
Journal: |
Brain Res Mol Brain Res |
Title: |
Identification of four novel human G protein-coupled receptors expressed in the brain. |
Volume: |
86 |
Issue: |
1-2 |
Pages: |
13-22 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gerard C |
Year: |
1994 |
Journal: |
Annu Rev Immunol |
Title: |
C5A anaphylatoxin and its seven transmembrane-segment receptor. |
Volume: |
12 |
|
Pages: |
775-808 |
|
•
•
•
•
•
|
Publication |
First Author: |
Roglic A |
Year: |
1996 |
Journal: |
Biochim Biophys Acta |
Title: |
cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure. |
Volume: |
1305 |
Issue: |
1-2 |
Pages: |
39-43 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gerard NP |
Year: |
1991 |
Journal: |
Nature |
Title: |
The chemotactic receptor for human C5a anaphylatoxin. |
Volume: |
349 |
Issue: |
6310 |
Pages: |
614-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Joost P |
Year: |
2002 |
Journal: |
Genome Biol |
Title: |
Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands. |
Volume: |
3 |
Issue: |
11 |
Pages: |
RESEARCH0063 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ames RS |
Year: |
2001 |
Journal: |
J Immunol |
Title: |
Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models. |
Volume: |
166 |
Issue: |
10 |
Pages: |
6341-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mathieu MC |
Year: |
2005 |
Journal: |
Immunol Lett |
Title: |
The C3a receptor antagonist SB 290157 has agonist activity. |
Volume: |
100 |
Issue: |
2 |
Pages: |
139-45 |
|
•
•
•
•
•
|
Publication |
First Author: |
Otto M |
Year: |
2004 |
Journal: |
J Biol Chem |
Title: |
C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism. |
Volume: |
279 |
Issue: |
1 |
Pages: |
142-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
Perrino MR |
Year: |
2024 |
Journal: |
Life Sci Alliance |
Title: |
C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis. |
Volume: |
7 |
Issue: |
5 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Farini A |
Year: |
2022 |
Journal: |
Cell Death Dis |
Title: |
Inhibition of the immunoproteasome modulates innate immunity to ameliorate muscle pathology of dysferlin-deficient BlAJ mice. |
Volume: |
13 |
Issue: |
11 |
Pages: |
975 |
|
•
•
•
•
•
|
Publication |
First Author: |
Biggins PJC |
Year: |
2017 |
Journal: |
J Neurotrauma |
Title: |
The Alternative Receptor for Complement Component 5a, C5aR2, Conveys Neuroprotection in Traumatic Spinal Cord Injury. |
Volume: |
34 |
Issue: |
12 |
Pages: |
2075-2085 |
|
•
•
•
•
•
|
Publication |
First Author: |
Desai JV |
Year: |
2023 |
Journal: |
Cell |
Title: |
C5a-licensed phagocytes drive sterilizing immunity during systemic fungal infection. |
Volume: |
186 |
Issue: |
13 |
Pages: |
2802-2822.e22 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kaur G |
Year: |
2023 |
Journal: |
PLoS One |
Title: |
Helicase-like transcription factor (Hltf)-deletion activates Hmgb1-Rage axis and granzyme A-mediated killing of pancreatic β cells resulting in neonatal lethality. |
Volume: |
18 |
Issue: |
8 |
Pages: |
e0286109 |
|
•
•
•
•
•
|
Publication |
First Author: |
Coulthard LG |
Year: |
2018 |
Journal: |
Mol Immunol |
Title: |
Complement C3a receptor modulates embryonic neural progenitor cell proliferation and cognitive performance. |
Volume: |
101 |
|
Pages: |
176-181 |
|
•
•
•
•
•
|
Publication |
First Author: |
Manouchehri N |
Year: |
2021 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
CD11c+CD88+CD317+ myeloid cells are critical mediators of persistent CNS autoimmunity. |
Volume: |
118 |
Issue: |
14 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Karsten CM |
Year: |
2017 |
Journal: |
J Immunol |
Title: |
Monitoring C5aR2 Expression Using a Floxed tdTomato-C5aR2 Knock-In Mouse. |
Volume: |
199 |
Issue: |
9 |
Pages: |
3234-3248 |
|
•
•
•
•
•
|
Publication |
First Author: |
Denk S |
Year: |
2017 |
Journal: |
J Immunol |
Title: |
Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects. |
Volume: |
198 |
Issue: |
12 |
Pages: |
4846-4854 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wu MCL |
Year: |
2020 |
Journal: |
J Immunol |
Title: |
Absence of the C5a Receptor C5aR2 Worsens Ischemic Tissue Injury by Increasing C5aR1-Mediated Neutrophil Infiltration. |
Volume: |
205 |
Issue: |
10 |
Pages: |
2834-2839 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shende R |
Year: |
2022 |
Journal: |
Front Immunol |
Title: |
Protective role of host complement system in Aspergillus fumigatus infection. |
Volume: |
13 |
|
Pages: |
978152 |
|
•
•
•
•
•
|
Publication |
First Author: |
Crass T |
Year: |
1996 |
Journal: |
Eur J Immunol |
Title: |
Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. |
Volume: |
26 |
Issue: |
8 |
Pages: |
1944-50 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
344
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
477
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
477
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
358
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
477
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
226
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
358
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Mahajan SD |
Year: |
2016 |
Journal: |
Immunology |
Title: |
C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus. |
Volume: |
148 |
Issue: |
4 |
Pages: |
407-19 |
|
•
•
•
•
•
|
Publication |
First Author: |
Seiler DL |
Year: |
2023 |
Journal: |
Front Immunol |
Title: |
The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita. |
Volume: |
14 |
|
Pages: |
1197709 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wiese AV |
Year: |
2017 |
Journal: |
PLoS One |
Title: |
The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells. |
Volume: |
12 |
Issue: |
9 |
Pages: |
e0184956 |
|
•
•
•
•
•
|
Publication |
First Author: |
Merle NS |
Year: |
2020 |
Journal: |
Front Immunol |
Title: |
Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis. |
Volume: |
11 |
|
Pages: |
1772 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
351
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
301
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
181
 |
Fragment?: |
true |
|
•
•
•
•
•
|